Literature DB >> 7702105

Waardenburg syndrome type II: phenotypic findings and diagnostic criteria.

X Z Liu1, V E Newton, A P Read.   

Abstract

The Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders. WS Type I has been mapped to the distal part of chromosome 2q and the gene identified as PAX3. Other gene(s) are responsible for WS Type II. Mapping WS Type II requires accurate diagnosis within affected families. To establish diagnostic criteria for WS Type II, 81 individuals from 21 families with Type II WS were personally studied, and compared with 60 personally studied patients from 8 families with Type I and 253 cases of WS (Type I or II) from the literature. Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II. Both were more common in Type II than in Type I. Other clinical manifestations, such as white forelock and skin patches, were more frequent in Type I. We estimate the frequency of phenotypic traits and propose diagnostic criteria for WS Type II. In practice, a diagnosis of WS Type II can be made with confidence given a family history of congenital hearing loss and pigmentary disorders, where individuals have been accurately measured for ocular distances to exclude dystopia canthorum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702105     DOI: 10.1002/ajmg.1320550123

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  35 in total

Review 1.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

Review 2.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

3.  Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A.

Authors:  Y Nobukuni; A Watanabe; K Takeda; H Skarka; M Tachibana
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

4.  Waardenburg syndrome type 2.

Authors:  Subhash Chandra Shaw; Shekhar Neema; Amit Devgan; Rakesh Maggon
Journal:  Med J Armed Forces India       Date:  2017-07-17

5.  Hearing dysfunction in heterozygous Mitf(Mi-wh) /+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome.

Authors:  Christina Ni; Deming Zhang; Lisa A Beyer; Karin E Halsey; Hideto Fukui; Yehoash Raphael; David F Dolan; Thomas J Hornyak
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-16       Impact factor: 4.693

Review 6.  Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Authors:  John D Gettelfinger; John P Dahl
Journal:  J Pediatr Genet       Date:  2018-01-04

7.  A Novel Pathogenic Variant in the MITF Gene Segregating with a Unique Spectrum of Ocular Findings in an Extended Iranian Waardenburg Syndrome Kindred.

Authors:  Nazanin Jalilian; Mohammad A Tabatabaiefar; Tayyeb Bahrami; Golaleh Karbasi; Mohammad H Bahramian; Abdolrahman Salimpoor; Mohammad R Noori-Daloii
Journal:  Mol Syndromol       Date:  2017-05-30

8.  Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Authors:  Andrea M Oza; Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Jaclyn B Murry; Linda Hasadsri; Kiyomitsu Nara; Margaret Kenna; Kevin T Booth; Hela Azaiez; Andrew Griffith; Karen B Avraham; Hannie Kremer; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

9.  Molecular Study of Three Lebanese and Syrian Patients with Waardenburg Syndrome and Report of Novel Mutations in the EDNRB and MITF Genes.

Authors:  N M Haddad; D Ente; E Chouery; N Jalkh; C Mehawej; Z Khoueir; V Pingault; A Mégarbané
Journal:  Mol Syndromol       Date:  2011-01-10

Review 10.  Cochlear implantation in common forms of genetic deafness.

Authors:  Richard J Vivero; Kenneth Fan; Simon Angeli; Thomas J Balkany; Xue Z Liu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-07-22       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.